              coverage rate, from 18% to 43.7% between 2012 and 2015, in partnership with MUSKOKA, COIA, UNFPA, WHO and UNICEF; the organization of advanced and mobile strategies (family planning, prenatal consultation, post-natal consultation and immunization); the increase in the geographical coverage rate of health facilities from 62% to 63% between 2012 and 2015, thanks to the construction of 32 new peripheral care units (types 1 and 2) in rural areas out of the 50 envisaged, the rehabilitation and extension of 11 specialized services and 68 existing peripheral care units (USPs); the Campaign to Accelerate the Reduction of Maternal and Newborn Mortality (CARMMA) launched in 2010; the subsidy of the caesarean section to the tune of 80% introduced in 2011, with an increase in the number of women cared for from 7,353 to 14, 095 in 2015; free intermittent preventive treatment of pregnant women; campaigns to repair obstetric fistula and care for women cured of this disease for their socio-professional reintegration. From 2011, the date of the beginning of the fight against this scourge, until November 2015, about 300 women between 17 and 65 years old suffering from obstetric fistula were operated free of charge and about forty of these women benefited from a reintegration in December 2015; Free antiretrovirals (ARVs) with an increase in the number of care facilities (54 to 141) and the dispensing of ARVs (5 to 69) between 2006 and 2012 and a geographic coverage rate of 49%; the National Institute of Health Insurance (INAM) pays 80% for pharmaceutical products and other care, 100% for childbirth and caesarean section operations, 90% for hospitalization); Supply of health facilities with reproductive health (RH) and consumable products; free distribution of long-lasting insecticidal nets (LLINs). Nearly 4,905,864 nets were distributed between 2012 and 2014; Community-based distribution of certain contraceptive methods (male and female condoms, supply of pills for women); the offer of family planning in a mobile strategy (implant and intrauterine device) and in an advanced mobile strategy (injectable and oral methods) in remote areas; provision of family planning equipment; supply of health facilities with contraceptive products. 163